Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

Bone Marrow Transplantation

Volumn 21, Issue 2, 1998, Pages 153-158

  Passweg, J R ^a   Tiberghien, P ^b   Cahn, J Y ^c   Vowels, M R ^d   Camitta, B M ^a   Gale, R P ^e   Herzig, R H ^f   Hoelzer, D ^g   Horowitz, M M ^a   Ifrah, N ^h   Klein, J P ^a   Marks, D I ⁱ   Ramsay, N K C ^j   Rowlings, P A ^a   Weisdorf, D J ^j   Zhang, M J ^a   Barrett, A J ^k  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Etablissement Transfus Sang F   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d SYDNEY CHILDREN'S HOSPITAL   (Australia)

^e Salick Health Care Inc   (United States)

^f UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^g GOETHE UNIVERSITY   (Germany)

^h Service des Maladies du Sang   (France)

ⁱ DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

ALL; B lineage; Bone marrow transplantation; Graft versus leukemia; T lineage

Indexed keywords

HLA ANTIGEN CLASS 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; DONOR; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; T CELL LEUKEMIA;

EID: 17744419349     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701064     Document Type: Article

References (27)

1. Barrett AJ. Bone marrow transplantation for acute lymphoblastit leukaemia. Baillières Clin Haematol 1994; 7: 377-401.
2. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720-1728.
3. Horowitz MM, Gale RP, Sondel PM et al Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
4. Horowitz MM, Truitt RL. Graft-versus-leukemia effects of bone marrow transplantation. In: Atkinson K (ed). Clinical Bone Marrow Transplantation. Cambridge University Press: Cambridge, 1994, pp 704-714.
5. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
6. Sondel PM, Hank JA, Molenda J et al. Relapse of host leukemia lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the 'graft versus leukemia' effect. Exp Hematol 1985; 13: 782-790.
7. Faber LM, Van Luxemburg-Heijs SA, Willemze R, Falkenburg JH. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992; 176: 1283-1289.
8. Faber LM, Van Luxemburg-Heijs SA, Veenhof WF et al. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood 1995; 86: 2821-2828.
9. Faber LM, Van der Hoeven J, Goulmy E et al. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest 1995; 96: 877-883.
10. Truitt RL, Atasoylu AA. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC compatible bone marrow. Bone Marrow Transplant 1991; 8: 51-58.
11. Salomo M, Steinmann J, Glass B et al. Leukemia-specific allogeneic donor T cells: Quantification by limiting dilution assay. Bone Marrow Transplant 1995; 15: 179-186.
12. Bach F, Sachs D. Current concepts in immunology: Transplantation immunology. New Engl J Med 1987; 317: 489-492.
13. Sosman JA, Oettel KR, Smith SD. Specific recognition of human leukemia cells by allogeneic T cells: evidence for HLA-D restricted determinants on leukemia cells that are cross-reactive with determinants present on unrelated non-leukemic cells. Blood 1990; 75: 2005-2016.
14. Greaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 1981; 41: 4752-4766.
15. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
16. Foon KA, Gale RP, Todd RF. Immunologic approaches to the classification of lymphomas and lymphoid leukemias. Cancer Treat Res 1988; 38: 1-30.
17. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993; 99: 504-512.
18. Ludwig WD, Raghavachar A, Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia. Baillières Clin Haematol 1994; 7: 235-262.
19. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
20. Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459-2464.
21. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187-220.
22. Weiden PL, Sullivan KM, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New Engl J Med 1981; 304: 1529-1533.
23. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New Engl J Med 1979; 300: 1068-1073.
24. Jacobsen N, Badsberg JH, Lonnqvist B et al. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant 1990; 5: 413-418.
25. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
26. Antin JH. Graft-versus-leukemia: no longer an epiphenomenon (editorial). Blood 1993; 82: 2273-2277.
27. Delain M, Tiberghien P, Racadot E et al. Variability of the alloreactive T-cell response to human leukemic blasts. Leukemia 1994; 8: 642-647.